Nuvectis Pharma, Inc. (NVCT) Stock Ticker
NVCT right now
Market factors today
Unlock the full NVCT picture
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
NVCT stock facts
| Ticker symbol | NVCT |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $536.6M |
| CEO | Ron Bentsur |
| Employees | 16 |
| Headquarters | Fort Lee, NJ, US |
| IPO date | 2022-02-04 |
| Website | www.nuvectis.com |
What you can see for NVCT on Tickr
Live NVCT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NVCT report.
Rankings
FAQ
What is the ticker symbol for Nuvectis Pharma, Inc.?
The ticker symbol for Nuvectis Pharma, Inc. is NVCT, listed on the NASDAQ Capital Market.
What is NVCT?
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug…